+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia

Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia

Hypertension 60(3): 712-721

Preeclampsia (PE) is a prevalent life-threatening hypertensive disorder of pregnancy associated with increased complement activation. However, the causative factors and pathogenic role of increased complement activation in PE are largely unidentified. Here we report that a circulating maternal autoantibody, the angiotensin II type 1 receptor agonistic autoantibody, which emerged recently as a potential pathogenic contributor to PE, stimulates deposition of complement C3 in placentas and kidneys of pregnant mice via angiotensin II type 1 receptor activation. Next, we provide in vivo evidence that selectively interfering with C3a signaling by a complement C3a receptor-specific antagonist significantly reduces hypertension from 167±7 to 143±5 mm Hg and proteinuria from 223.5±7.5 to 78.8±14.0 μg of albumin per milligram creatinine (both P<0.05) in angiotensin II type 1 receptor agonistic autoantibody-injected pregnant mice. In addition, we demonstrated that complement C3a receptor antagonist significantly inhibited autoantibody-induced circulating soluble fms-like tyrosine kinase 1, a known antiangiogenic protein associated with PE, and reduced small placental size with impaired angiogenesis and intrauterine growth restriction. Similarly, in humans, we demonstrate that C3 deposition is significantly elevated in the placentas of preeclamptic patients compared with normotensive controls. Lastly, we show that complement C3a receptor activation is a key mechanism underlying autoantibody-induced soluble fms-like tyrosine kinase 1 secretion and decreased angiogenesis in cultured human villous explants. Overall, we provide mouse and human evidence that angiotensin II type 1 receptor agonistic autoantibody-mediated activation contributes to elevated C3 and that complement C3a receptor signaling is a key mechanism underlying the pathogenesis of the disease. These studies are the first to link angiotensin II type 1 receptor agonistic autoantibody with complement activation and to provide important new opportunities for therapeutic intervention in PE.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 051721546

Download citation: RISBibTeXText

PMID: 22868393

DOI: 10.1161/hypertensionaha.112.191817

Related references

Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling. Hypertension 55(5): 1246-1253, 2010

[Op.5D.04] Complement C5A-Mediated Placental Dysfunction Contributes To The Pathogenesis Of Preeclampsia. Journal of Hypertension 34: e63-e64, 2016

Macrophage scavenger receptor 1 contributes to pathogenesis of fulminant hepatitis via neutrophil-mediated complement activation. Journal of Hepatology 68(4): 733-743, 2018

Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia. Circulation 121(3): 436-444, 2010

Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia. Hypertension 61(2): 472-479, 2013

Response to questionable role of the angiotensin II receptor subtype 1 autoantibody in the pathogenesis of preeclampsia: There is no single universal preeclampsia cause. Hypertension (Baltimore) 50(1): E4, 2007

FRI0517Possible Role for Autoantibody-Mediated Activation of Immume Cells Mediated through the Angiotensin II Receptor Type 1 and the Endothelin Receptor Type A in the Pathogenesis of Systemic Sclerosis. Annals of the Rheumatic Diseases 73(Suppl 2): 574.3-574, 2014

Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia. Journal of Immunology 186(10): 6024-6034, 2011

Interfering with Gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia. Proceedings of the National Academy of Sciences of the United States of America 110(28): 11451-6, 2013

Questionable role of the angiotensin II receptor subtype 1 autoantibody in the pathogenesis of preeclampsia. Hypertension 50(1): E3; Author Reply E4-E3; Author Reply E4, 2007

Complement Split Products C3a/C5a and Receptors: Are They Regulated by Circulating Angiotensin II Type 1 Receptor Autoantibody in Severe Preeclampsia?. Gynecologic and Obstetric Investigation 81(1): 28-33, 2016

Glucocorticoid receptor β regulates injury-mediated astrocyte activation and contributes to glioma pathogenesis via modulation of β-catenin/TCF transcriptional activity. Neurobiology of Disease 59: 165-176, 2013

Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors. Proceedings of the National Academy of Sciences of the United States of America 103(49): 18697-18702, 2006

Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. Mbio 9(5):, 2018

Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenia ITP. 2011